← The Wire
BMEANasdaq
Biomea Fusion, Inc.
Pharmaceutical Preparations · DE · CIK 1840439
Develops oral, small molecule drugs for diabetes, obesity, and metabolic diseases
$85M
Market cap
$1.39
Last close
+5.3%
1D
+13.0%
5D
1.2M
Volume
Price · last 39 sessions-6.1%
May 4L $1.14 · H $1.63Jun 29
121
Total filings
Jun 11, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 11, 202610-Q10-QMay 11, 20268-KResults of OperationsMay 11, 20268-KReg FD Disclosure · Company UpdateApr 28, 2026DEF 14ADEF 14AApr 27, 202610-K10-KMar 24, 20268-KResults of OperationsMar 24, 20268-KReg FD DisclosureFeb 25, 20268-KReg FD Disclosure · Company UpdateJan 14, 202610-Q10-QNov 4, 20258-KResults of OperationsNov 4, 20258-KMaterial Agreement · Company UpdateOct 7, 2025424B5424B5Oct 7, 2025424B5424B5Oct 6, 20258-KCompany UpdateOct 6, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KExecutive ChangeJul 24, 20258-KMaterial AgreementJun 20, 20258-KMaterial Agreement · Company UpdateJun 18, 2025424B5424B5Jun 18, 2025424B5424B5Jun 17, 20258-KReg FD Disclosure · Company UpdateJun 17, 20258-KShareholder VoteJun 13, 202510-Q10-QMay 5, 20258-KResults of OperationsMay 5, 2025DEF 14ADEF 14AApr 28, 202510-K10-KMar 31, 20258-KResults of OperationsMar 31, 20258-KDelisting Notice · Executive ChangeMar 27, 20258-KExecutive ChangeFeb 28, 20258-KCompany UpdateJan 15, 20258-KReg FD Disclosure · Company UpdateDec 20, 20248-KReg FD Disclosure · Company UpdateOct 31, 202410-Q10-QOct 29, 20248-KResults of OperationsOct 29, 20248-KCompany UpdateSep 27, 202410-Q10-QJul 31, 20248-KResults of OperationsJul 31, 20248-KShareholder VoteJun 12, 20248-KCompany UpdateJun 7, 20248-KResults of OperationsMay 2, 202410-Q10-QMay 2, 2024DEF 14ADEF 14AApr 26, 2024SC 13GSC 13GApr 10, 20248-KCompany UpdateApr 1, 20248-KResults of OperationsApr 1, 202410-K10-KMar 28, 20248-KCompany UpdateMar 7, 2024SC 13GSC 13GFeb 8, 2024SC 13GSC 13GJan 29, 20248-KCompany UpdateJan 10, 202410-Q10-QOct 30, 20238-KResults of OperationsOct 30, 202310-Q10-QJul 31, 20238-KResults of OperationsJul 31, 20238-KCompany UpdateJul 25, 20238-KShareholder VoteJun 15, 2023SC 13GSC 13GMay 10, 20238-KCompany UpdateMay 2, 202310-Q10-QMay 2, 20238-KResults of OperationsMay 2, 2023DEF 14ADEF 14AApr 28, 20238-KMaterial Agreement · Company UpdateApr 3, 2023424B5424B5Mar 30, 2023424B5424B5Mar 29, 20238-KReg FD Disclosure · Company UpdateMar 28, 202310-K10-KMar 28, 20238-KResults of OperationsMar 28, 2023SC 13GSC 13GFeb 14, 20238-KCompany UpdateJan 12, 20238-KCompany UpdateDec 16, 20228-KCompany UpdateDec 13, 20228-KMaterial AgreementNov 25, 2022424B5424B5Nov 25, 202210-Q10-QNov 7, 20228-KResults of OperationsNov 7, 20228-KCompany UpdateNov 1, 20228-KCompany UpdateOct 18, 20228-KCompany UpdateSep 23, 2022
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Dec 11, 2025: 2 insiders bought $196K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 11, 2025 | Erdtmann Rainer MSee Remarks | Buy | 30,000 | $1.43 | $43K |
| Dec 2, 2025 | Hitchcock Michael J.M.Interim CEO | Buy | 100,000 | $0.99 | $99K |
| Dec 1, 2025 | Erdtmann Rainer MSee Remarks | Buy | 10,000 | $1.05 | $11K |
| Nov 28, 2025 | Erdtmann Rainer MSee Remarks | Buy | 40,000 | $1.10 | $44K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance